1 not yet recruiting, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Withdrawn 1 |
Follow LNG-IUD (Progestin): new trials by email Literature Review of LNG-IUD (Progestin) trials Research Report on LNG-IUD (Progestin)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer Semaglutide (Wegovy) weekly injection, LNG-IUD (Progestin), Structured Weight Loss Program - Endometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | Phase 2 | Not yet recruiting | The Methodist Hospital Research Institute | 48 | 2027-01-01 | 2026-10-01 |
| Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia Semaglutide, Placebo, LNG-IUD (Progestin) - Endometrial Hyperplasia | Phase 2 | Withdrawn | Washington University School of Medicine | 2025-03-12 | 2026-01-12 |
Endometrial Hyperplasia (2) · Endometrial Neoplasms (1) · Obesity (1) · Overweight (1) · Weight Loss (1)
The Methodist Hospital Research Institute (1) · Washington University School of Medicine (1)
United States (1)